Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

22.43
Delayed Data
As of Sep 22
 +0.56 / +2.56%
Today’s Change
11.41
Today|||52-Week Range
24.88
+82.80%
Year-to-Date

Today’s Trading

Previous close21.87
Today’s open21.86
Day’s range21.75 - 22.59
Volume1,469,103
Average volume (3 months)1,186,776
Market cap$3.5B
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book39.00

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc-4.03-4.19%
ONCESpark Therapeutics I...-1.95-2.24%
XONIntrexon Corp0.000.00%
JUNOJuno Therapeutics In...+3.52+8.46%
Data as of 4:02pm ET, 09/22/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.17
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts